- Zydus Cadila has won approval for its saroglitazar to be used as the treatment of non-cirrhotic nonalcoholic steatohepatitis (NASH) in India.
- The green light from the Drug Controller General of India (DCGI) makes saroglitazar the first drug in the world approved for this indication.